About Our Team
GranuFlo Case Settlement Consulting
Full-Service Medical Legal Support in Pharmaceutical Mass Tort: (561) 998-7600
GranuFlo is one of the most common dry acid products prescribed for kidney dialysis. Patients receiving the GranuFlo product suffered severe cardiac complications resulting in significant injury and, in some cases, death. Recently, the Plaintiffs Steering Committee and the Attorneys for Fresenius, the manufacturer of Granfulo, reached an agreement to settle these cases for $250 million.
In these cases, as with all medical device and pharmaceutical cases, the settlement process requires a comprehensive medical and scientific evaluation of medical records. Our team of nurse-paralegals, medical doctors, and attorneys work together to create medical record claims packages and comprehensive reports outlining key events and estimated settlement values.
At Physicians Medical Review, our team of in-house physicians and attorneys provides full-service support for pharmaceutical litigation, which includes:
- Medical Case Reviews
- Authoring Comprehensive Medical Opinions
- Intake Screening
- Organizing and Summarizing Medical Records
- Settlement Claims Package Development
GranuFlo Litigation Case Review
According to the FDA, GranuFlo carries serious health risks such as:
- Low blood pressure
- Heart arrhythmia
- Low blood oxygen pressure
- Low potassium levels in blood
- High carbon dioxide concentration in the blood
- Cardiac arrest
Contact Physicians Medical Review
We can deliver the level of medicolegal consulting to assist you with all aspects of your GranuFlo claim. We provide all the medical support you need to facilitate the efficient settlement of your case.
Find out more about our litigation and settlement support when you contact Physicians Medical Review at (561) 998-7600.